Back
Results - Announcements
Lyka Labs Ltd consolidated sales up 50.95% on year in Q2FY2026
10-Aug-2026, 02:43
Lyka Labs Ltd share price declined by 2% to Rs 67.62 after the company's net profit tumbled by 125.40% to Rs 2.05 crore, while revenue from operations increased sharply by 50.95% to Rs 42.31 crore in Q2FY26 over Q1FY26. The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 24.54 lakh crore, easing 5.14%. It has improved by 0.74% over last one week and rose by 13.39% in last one month while the market capitalization of Lyka Labs Ltd has inched up 6.91% and 10.92% in the same period respectively. Profit before tax (PBT) of Lyka Labs Ltd stood at Rs 1.95 crore in Q2 FY26, expanding by 44.44% year-on-year, and tanking 122.70% quarter-on-quarter. EBITDA came in at Rs 4 crore, jumping 35.41% YoY and plunging by 158.42% sequentially. Total expenses posted a minor rise of 8.87% to Rs 39.77 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 11.2 crore, surging by 50.74% YoY, while employee benefits expense was at Rs 11.49 crore, falling 11% YoY. For the TTM ended FY26, revenue from operations declined slightly by 7.26% to Rs 128.44 crore, while net profit plunged by 231.65% to Rs 10.44 crore, compared to previous TTM. EBITDA soared by 1640% to Rs 7.16 crore, and PBT collapsed by 205.94% to Rs 11.78 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 5.24 crore in FY26, as against Rs 1.9 crore in FY25. Lyka Labs Ltd nosedived by 35.94% in last one year, underperforming the benchmark BSE Sensex which has eased by 2.63% during the same period.
Lyka Labs Ltd share price declined by 2% to Rs 67.62 after the company's net profit tumbled by 125.40% to Rs 2.05 crore, while revenue from operations increased sharply by 50.95% to Rs 42.31 crore in Q2FY26 over Q1FY26. The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 24.54 lakh crore, easing 5.14%. It has improved by 0.74% over last one week and rose by 13.39% in last one month while the market capitalization of Lyka Labs Ltd has inched up 6.91% and 10.92% in the same period respectively. Profit before tax (PBT) of Lyka Labs Ltd stood at Rs 1.95 crore in Q2 FY26, expanding by 44.44% year-on-year, and tanking 122.70% quarter-on-quarter. EBITDA came in at Rs 4 crore, jumping 35.41% YoY and plunging by 158.42% sequentially. Total expenses posted a minor rise of 8.87% to Rs 39.77 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 11.2 crore, surging by 50.74% YoY, while employee benefits expense was at Rs 11.49 crore, falling 11% YoY. For the TTM ended FY26, revenue from operations declined slightly by 7.26% to Rs 128.44 crore, while net profit plunged by 231.65% to Rs 10.44 crore, compared to previous TTM. EBITDA soared by 1640% to Rs 7.16 crore, and PBT collapsed by 205.94% to Rs 11.78 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 5.24 crore in FY26, as against Rs 1.9 crore in FY25. Lyka Labs Ltd nosedived by 35.94% in last one year, underperforming the benchmark BSE Sensex which has eased by 2.63% during the same period.